Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010

HE Davies, RJO Davies, CWH Davies - Thorax, 2010 - thorax.bmj.com
HISTORICAL PERSPECTIVE, PATHOPHYSIOLOGY AND BACTERIOLOGY OF PLEURAL
INFECTION This section provides background information for reference, interest and to set …

Sleep· 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history

JR Stradling, RJO Davies - Thorax, 2004 - thorax.bmj.com
Arguments over the definition of obstructive sleep apnoea/hypopnoea syndrome (OSAHS)
have still not been satisfactorily resolved. As a result, robust estimates of the prevalence of …

A systematic review of continuous positive airway pressure for obstructive sleep apnoea–hypopnoea syndrome

…, HLA Weatherly, JR Stradling, RJO Davies… - Sleep medicine …, 2009 - Elsevier
We conducted a systematic review of current evidence on the effectiveness of continuous
positive airway pressure (CPAP) for treatment of obstructive sleep apnoea–hypopnoea …

Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial

…, R Mullins, C Jenkinson, JR Stradling, RJO Davies - The Lancet, 2002 - thelancet.com
Background Obstructive sleep apnoea is associated with raised blood pressure. If blood
pressure can be reduced by nasal continuous positive airway pressure (nCPAP), such …

[HTML][HTML] UK controlled trial of intrapleural streptokinase for pleural infection

…, DJ Lane, JH Darbyshire, RJO Davies - … England Journal of …, 2005 - Mass Medical Soc
Background Intrapleural fibrinolytic agents are used in the drainage of infected pleural-fluid
collections. This use is based on small trials that did not have the statistical power to …

Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial

C Jenkinson, RJO Davies, R Mullins, JR Stradling - The Lancet, 1999 - thelancet.com
… Robert Davies was also responsible for study design and execution. Rebecca Mullins was
responsible for entry of patients to the study, collection of clinical measurements, and data …

[HTML][HTML] Intrapleural use of tissue plasminogen activator and DNase in pleural infection

…, FV Gleeson, AJ Nunn, RJO Davies - … England Journal of …, 2011 - Mass Medical Soc
Background More than 30% of patients with pleural infection either die or require surgery.
Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did …

Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized …

…, A Prasad, N Crosthwaite, YCG Lee, RJO Davies… - Jama, 2012 - jamanetwork.com
Davies reported serving on the speakers' bureau for AstraZeneca. Dr Lee reported receiving
honoraria from CareFusion and Sequana Medical as an advisory board member. Dr Miller …

A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis

…, N Peshu, TN Williams, K Maitland, RJO Davies… - Nature …, 2007 - nature.com
Toll-like receptors (TLRs) and members of their signaling pathway are important in the
initiation of the innate immune response to a wide variety of pathogens 1 , 2 , 3 . The adaptor …

Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial

NA Maskell, FV Gleeson, RJO Davies - The Lancet, 2003 - thelancet.com
Background Over 200 000 pleural effusions are attributable to cancer in the UK and USA every
year. Cytological examination of pleural fluid classifies about 60% of malignant effusions. …